Four Ukrainian pharmaceutical companies testing drugs to treat COVID-19

Four Ukrainian pharmaceutical companies testing drugs to treat COVID-19

Ukrinform
Four Ukrainian pharmaceutical companies are testing drugs to treat coronavirus disease (COVID-19), according to a statement posted on the website of the Ukrainian National Security and Defense Council (NSDC).

"JSC Farmak, PJSC Research and Industrial Center Borschahivka Chemical and Pharmaceutical Plant, LLC Biopharma Plasma and ALC InterChem are conducting clinical trials of drugs for the treatment of coronavirus disease (COVID-19), including symptomatic treatment," the statement reads.

According to the State Expert Center of the Ministry of Health, clinical trials of four drugs to treat COVID-19 have been registered in Ukraine to date – Amizon® Max (manufactured by JSC Farmak), Amixin® ІС (Interchem), Corvitin® (Borschahivka Chemical and Pharmaceutical Plant), and Bioven (Biopharma Plasma).

All these drugs are registered in Ukraine, so they are allowed for use and have long been known, but the instructions for their use do not contain information on the treatment of COVID-19, the NSDC said.

"Ukraine has a sufficient number of highly professional specialists and pharmaceutical companies capable of creating the necessary drugs and vaccines to treat COVID-19," NSDC Secretary Oleksiy Danilov said.

op


Let’s get started read our news at facebook messenger > > > Click here for subscribe

While citing and using any materials on the Internet, links to the website ukrinform.net not lower than the first paragraph are mandatory. In addition, citing the translated materials of foreign media outlets is possible only if there is a link to the website ukrinform.net and to the website of a foreign media outlet. Citing and using materials in offline media, mobile apps, Smart TV are allowed only with written permission from Ukrinform. News and publications marked as "Advertisement" and "PR" and articles in the section "Releases" include promoted content, and an advertiser is responsible for the content.

© 2015-2020 Ukrinform. All rights reserved.

Website design Studio Laconica

Extended searchHide extended search
By period:
-